Skip to main content
. 2021 Dec 8;10(12):1587. doi: 10.3390/pathogens10121587

Figure 3.

Figure 3

Pretreatment drug resistance in ART-naïve and prior ARV-exposed individuals in Mexico City, 2020. PDR levels are shown for a subset of 1348 participants enrolled from June to December 2020 (data on ARV exposure for 62 participants are missing), for whom data on prior exposure to antiretrovirals were available. Individuals with HIV PDR were defined as those having a score ≥ 15 to any of the drugs in the corresponding category, as defined in the Methods. Error bars represent 95% confidence intervals. Comparisons were made with Fisher’s exact test. PDR; pretreatment drug resistance; PI, protease inhibitor; RTI, reverse transcriptase inhibitor; NRTI, nucleoside reverse transcriptase inhibitor; NNRTI, non-nucleoside reverse transcriptase inhibitor; INSTI, integrase strand-transfer inhibitor; EVG, elvitegravir; RAL, raltegravir; BIC, bictegravir; CAB, cabotegravir; DTG, dolutegravir.